Panel Discussion | Radiation Protection - Call for Action

Saturday, March 7, 2026

11:52 AM - 12:10 PM EST

Location: Spotlight Theater

Moderator(s)

James B. Hermiller, MD, FACC, MSCAI

Director Interventional Cardiology
St. Vincent Medical Group
Indianapolis, Indiana, United States

No relationships to disclose
Dean J. Kereiakes, MD, FACC, MSCAI

Chairman, The Christ Hospital Heart and Vascular Institute; Medical Director, The Christ Hospital Research Institute; Professor of Clinical Medicine, The Ohio State University
The Christ Hospital Health Network
Cincinnati, Ohio, United States

No relationships to disclose

Panel Discussant(s)

David Cox, MD, MSCAI

Interventional Cardiologist
Sanger HVI Charlotte NC
Charlotte, North Carolina, United States

Disclosure information not submitted.
Rhian E. Davies, DO MS

Interventional Cardiology
WellSpan York Hospital
Annville, Pennsylvania, United States

Disclosure information not submitted.
Morton J. Kern, MD, MSCAI, FACC, FAHA

Interventional Cardiologist
VA Long Beach Health Care System
Long Beach, California, United States

No relationships to disclose
Kenneth Rosenfield, MD, MHCDS

section head, vascular medicine and intervention
Massachusetts General Hospital
boston, Massachusetts, United States

Disclosure information not submitted.
Eric A. Secemsky, MD, MSc

Director of Vascular Intervention
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

No relationships to disclose
Evan Shlofmitz, DO

Director of Intravascular Imaging
St. Francis Hospital - The Heart Center
Roslyn, New York, United States

No relationships to disclose
Gerald S. Werner, MD, PhD, FSCAI

Senior Consultant CTO
University Heart Center Frankfurt/Main
Frankfurt am Main, Hessen, Germany

No relationships to disclose

Disclosure(s):

James B. Hermiller, MD, FACC, MSCAI: Edwards, Abbott: Consulting Fees (e.g., advisory boards) (Ongoing)

Dean J. Kereiakes, MD, FACC, MSCAI: Ablative Solutions, Inc.: Stock Options [in privately held companies] (Ongoing); CeleCor Therapeutics: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Egg Medical, Inc: Stock Options [in privately held companies] (Ongoing); Elixir Medical Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Foldax: Consulting Fees (e.g., advisory boards) (Ongoing); OrchestraBiomed: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Sino Medical Sciences Technology, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing)

Rhian E. Davies, DO MS: Terumo: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Morton J. Kern, MD, MSCAI, FACC, FAHA: Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abbott Vascular, Abiomed, ACIST medical, Boston Scientific, Cardialysis BV, CardiacBooster, Kaminari Medical, ReCor Medical, PulseCath, Pie Medical, Sanofi, Siemens Health Care and Medtronic.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Eric A. Secemsky, MD, MSc: Abbott, Asahi, BD, Boston Scientific, Conavi, Cook, Cordis, Endovascular Engineering, Evident Vascular, Gore, InfraRedx, Medtronic, Penumbra, Philips, RapidAI, Rampart IC, R3, Regeneron, Shockwave, Siemens, SoniVie, Teleflex, Terumo, Thrombolex, Vent: Consulting Fees (e.g., advisory boards) (Ongoing)

Evan Shlofmitz, DO: ABBOTT VASCULAR, ACIST MEDICAL, BOSTON SCIENTIFIC, CHIESI, HEARTFLOW, GENTUITY, MEDTRONIC, PHILIPS, RADIACTION, SHOCKWAVE MEDICAL, TERUMO: Consulting Fees (e.g., advisory boards) (Ongoing); AMGEN, NOVO NORDISK: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Gerald S. Werner, MD, PhD, FSCAI: No financial relationships to disclose